Search
Close this search box.

Sequence Newsletter

IMPACT

Genome Atlantic has consistently strived to drive meaningful impact through all our activities. Realizing the importance of quantifying this impact, we recently enlisted The Evidence Network to conduct a comprehensive Impact Assessment spanning the five-year period from 2018 to 2023. Their findings pointed to a remarkable return on investment and tangible outcomes:

  • Every public sector dollar invested in Genome Atlantic yielded $23 in applied R&D investment and $59 to GDP.
  • Genome Atlantic’s efforts enabled $60 million in new impact-driven genomics R&D – of which $21 million or roughly 30%, was private sector investment.
  • Total funds attracted by and invested in Genome Atlantic during the last five years resulted in an estimated $178.7 million of output, $122.2 million contributions to GDP, $8.9 million in provincial and federal tax revenues, and 927 jobs.
  • The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.

The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.

IMPACT

Genome Atlantic has consistently strived to drive meaningful impact through all our activities. Realizing the importance of quantifying this impact, we recently enlisted The Evidence Network to conduct a comprehensive Impact Assessment spanning the five-year period from 2018 to 2023. Their findings pointed to a remarkable return on investment and tangible outcomes:

  • Every public sector dollar invested in Genome Atlantic yielded $23 in applied R&D investment and $59 to GDP.
  • Genome Atlantic’s efforts enabled $60 million in new impact-driven genomics R&D – of which $21 million or roughly 30%, was private sector investment.
  • Total funds attracted by and invested in Genome Atlantic during the last five years resulted in an estimated $178.7 million of output, $122.2 million contributions to GDP, $8.9 million in provincial and federal tax revenues, and 927 jobs.
  • The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.

The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.

Featured Stories

Genomics is a green technology that is helping Atlantic Canadian companies and industries to grow more sustainably and to reduce their carbon footprint. Watch our new Genomics and Sustainability video to find out how Genome Atlantic works with Atlantic Canadians in many sectors across the region is helping to strengthen our natural resource industries and shape a greener, better future.

Exploring the intersection of genomics and mining reveals a realm rich with potential applications poised to transform industry practices. Recently, Genome Atlantic collaborated with the Mining Innovation Commercialization Accelerator (MICA) and the College of the North Atlantic Genomics to host a webinar on “Sustainable Solutions: Genomics in Mining”.  The event attracted a diverse audience eager to learn about the practical applications of genomics for bioleaching, bioremediation and environmental monitoring. Notable experts Ross Orr of BacTech, Cassy Appelt of Koonie, and Dr. Mehrdad Hajibabei of eDNAtec shared valuable insights. Their contributions shed light on the promising avenues genomics offers for enhancing production, sustainability, and biodiversity management within mining operations. 

End Of Current Issue

Sign up for our free newsletter.

We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.

Read recent issues here.

Sign up for our free newsletter.

We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.

Read recent issues here.